We are live on ! Find out more
EWTX icon

Edgewise Therapeutics
EWTX

58 hedge funds and large institutions have $769M invested in Edgewise Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 4

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

21% more funds holding

Funds holding: 48 → 58 (+10)

4.58% more ownership

Funds ownership: 97.52% → 102.09% (+4.6%)

3% less capital invested

Capital invested by funds: $796M → $769M (-$26.4M)

Holders
58
Holders Change
+10
Holders Change %
+20.83%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
17
Increased
25
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$26.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11M
3
State Street
State Street
Massachusetts
+$5.93M
4
CAM
Cormorant Asset Management
Massachusetts
+$3.51M
5
Northern Trust
Northern Trust
Illinois
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.8M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$9.95M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.7M
4
CS
Credit Suisse
Switzerland
-$1.63M
5
OCA
Octagon Capital Advisors
New York
-$830K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$213M – – –
NHAS
2
Novo Holdings A/S
Denmark
$85.4M – – –
DM
3
Deerfield Management
New York
$60.1M – – –
CAM
4
Cormorant Asset Management
Massachusetts
$54.5M +$3.51M +194,987 +6%
Viking Global Investors
5
Viking Global Investors
Connecticut
$41.7M – – –
RCM
6
RA Capital Management
Massachusetts
$39.9M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$38.2M -$11.8M -654,573 -21%
Citadel Advisors
8
Citadel Advisors
Florida
$37.6M +$598K +33,257 +1%
BlackRock
9
BlackRock
New York
$31.3M +$26.4M +1,467,371 +253%
NLVP
10
New Leaf Venture Partners
New York
$23.7M – – –
Janus Henderson Group
11
Janus Henderson Group
United Kingdom
$23.3M -$3.7M -205,688 -12%
EC
12
EcoR1 Capital
California
$19.5M – – –
Vanguard Group
13
Vanguard Group
Pennsylvania
$18.3M +$11M +611,879 +104%
LGM
14
Logos Global Management
California
$13M +$3.03M +168,188 +25%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$10.4M – – –
State Street
16
State Street
Massachusetts
$8.08M +$5.93M +329,542 +166%
BBA
17
Baker Bros. Advisors
New York
$7.64M – – –
WP
18
Woodline Partners
California
$6.16M +$738K +41,028 +11%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$5.98M +$2.67M +148,663 +61%
American Century Companies
20
American Century Companies
Missouri
$4.65M +$179K +9,967 +3%
Northern Trust
21
Northern Trust
Illinois
$4.62M +$3.36M +186,617 +161%
Norges Bank
22
Norges Bank
Norway
$4.61M – – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$3.28M +$3.22M +179,099 +506%
Federated Hermes
24
Federated Hermes
Pennsylvania
$2.25M -$9.95M -552,925 -79%
Charles Schwab
25
Charles Schwab
California
$2.15M +$1.01M +56,285 +67%
1
2 3

EWTX Hedge Fund Activity: Q4 2021 in Review

58 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q4 2021, worth a combined $769M — down 3.3% from $796M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new EWTX positions and 7 closed out — a net gain of 10 holders — while 25 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Fidelity Investments, cutting an estimated $11.8M.

  • 58 institutional investors held Edgewise Therapeutics (EWTX) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $769M of Edgewise Therapeutics stock for Q4 2021, down 3.3% quarter-over-quarter.
  • 17 funds opened new Edgewise Therapeutics positions in Q4 2021 and 7 closed out, a net change of +10 holders.
  • The largest Edgewise Therapeutics buyer in Q4 2021 was BlackRock, an estimated $26.4M added.
  • The largest Edgewise Therapeutics seller in Q4 2021 was Fidelity Investments, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2021.